Deciphering FAK in intrahepatic cholangiocarcinoma: A novel therapeutic target?

Javier Vaquero1, Verena Keitel2

  • 1TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

Journal of Hepatology
|July 12, 2021
PubMed
Abstract

No abstract available in PubMed .